OIG reprimands NIH for not enforcing trial transparency requirements

Regulatory News

Regulatory NewsFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsComplianceDiagnostics/IVDsMedical DevicesNorth AmericaOtherPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development